TEM

TEM

USD

Tempus AI Inc. Class A Common Stock

$84.490-0.565 (-0.664%)

वास्तविक समय मूल्य

Healthcare
Health Information Services
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$85.055

उच्च

$88.880

कम

$83.940

मात्रा

8.89M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

14.7B

उद्योग

Health Information Services

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

9.33M

एक्सचेंज

NMS

मुद्रा

USD

52-सप्ताह रेंज

कम $31.36वर्तमान $84.490उच्च $104.32

संबंधित समाचार

BusinessWire

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim

और देखें
Tempus to Participate in the Stifel 2025 Healthcare Conference
Analyst Upgrades

Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105

Piper Sandler analyst David Westenberg maintains Tempus AI with a Neutral and raises the price target from $70 to $105.

और देखें
Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105
Analyst Upgrades

BTIG Maintains Buy on Tempus AI, Raises Price Target to $96

BTIG analyst Mark Massaro maintains Tempus AI with a Buy and raises the price target from $85 to $96.

और देखें
BTIG Maintains Buy on Tempus AI, Raises Price Target to $96
BusinessWire

Tempus to Report Third Quarter 2025 Financial Results on November 4

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter of 2025 on November 4, 2025. The company will hold the

और देखें
Tempus to Report Third Quarter 2025 Financial Results on November 4
BusinessWire

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European Society for Medical

और देखें
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
BusinessWire

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।